The latest closing stock price for Contineum Therapeutics as of November 04, 2024 is 16.56.
An investor who bought $1,000 worth of Contineum Therapeutics stock at the IPO in 2024 would have $75 today, roughly 0 times their original investment - a 7.53% compound annual growth rate over 1 years.
The all-time high Contineum Therapeutics stock closing price was 21.75 on July 16, 2024.
The Contineum Therapeutics 52-week high stock price is 22.00, which is 32.9% above the current share price.
The Contineum Therapeutics 52-week low stock price is 13.27, which is 19.9% below the current share price.
The average Contineum Therapeutics stock price for the last 52 weeks is 17.55.
An investor who bought $1,000 worth of Contineum Therapeutics stock at the IPO in 2024 would have $75 today, roughly 0 times their original investment - a 7.53% compound annual growth rate over 1 years.
The all-time high Contineum Therapeutics stock closing price was 21.75 on July 16, 2024.
The Contineum Therapeutics 52-week high stock price is 22.00, which is 32.9% above the current share price.
The Contineum Therapeutics 52-week low stock price is 13.27, which is 19.9% below the current share price.
The average Contineum Therapeutics stock price for the last 52 weeks is 17.55.